Free Trial
NASDAQ:QNTM

Quantum Biopharma (QNTM) Stock Price, News & Analysis

Quantum Biopharma logo
$26.14 +1.57 (+6.39%)
Closing price 08/6/2025 04:00 PM Eastern
Extended Trading
$26.18 +0.04 (+0.13%)
As of 08/6/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Quantum Biopharma Stock (NASDAQ:QNTM)

Key Stats

Today's Range
$24.37
$26.50
50-Day Range
$12.58
$35.00
52-Week Range
$2.70
$38.25
Volume
121,678 shs
Average Volume
153,957 shs
Market Capitalization
$76.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive QNTM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quantum Biopharma and its competitors with MarketBeat's FREE daily newsletter.

QNTM Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
Quantum BioPharma Makes Strategic Investment in GameStop
See More Headlines

QNTM Stock Analysis - Frequently Asked Questions

Quantum Biopharma's stock was trading at $3.68 at the beginning of 2025. Since then, QNTM stock has increased by 610.3% and is now trading at $26.14.

Quantum Biopharma Ltd. (NASDAQ:QNTM) issued its quarterly earnings data on Wednesday, August, 6th. The company reported ($3.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by $3.06.

Top institutional shareholders of Quantum Biopharma include AdvisorShares Investments LLC (1.27%).

Shares of QNTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Quantum Biopharma investors own include Jiuzi (JZXN), Aethlon Medical (AEMD), Aditxt (ADTX), Adial Pharmaceuticals (ADIL), Avalon GloboCare (ALBT), Ainos (AIMD) and AMC Entertainment (AMC).

Company Calendar

Last Earnings
5/14/2025
Today
8/06/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:QNTM
Previous Symbol
NASDAQ:QNTM
CIK
1771885
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($15.98)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.20 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-155.20%
Return on Assets
-94.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.96
Quick Ratio
0.95

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.54 per share
Price / Book
5.75

Miscellaneous

Outstanding Shares
2,910,000
Free Float
2,660,000
Market Cap
$75.97 million
Optionable
N/A
Beta
0.71
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:QNTM) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners